Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricCVSCVS HealthCICignaDGXQuest Diagnostics
Snapshot
Price$87.62$275.05$236.27
Market cap$133.62B$76.12B$23.88B
Valuation
P/E37.8x11.6x25.4x
Forward P/E54.1x8.9x22.1x
Growth
Revenue growth7.6%8.8%11.0%
EPS growth-46.0%30.5%14.9%
Profitability
Net margin0.7%2.3%9.1%
ROE3.9%15.2%14.1%
Balance sheet & cash
Debt / equity0.86x0.75x0.82x
Free cash flow yield9.9%9.7%5.4%
Dividend yield2.6%2.1%1.7%
Verdict
Investment ratingWeak· 36Favorable· 60Neutral· 52

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearCVStoday $88CItoday $275DGXtoday $236
2027$67.03 – $98.31+12% CAGR$269.14 – $394.74+44% CAGR$203.57 – $298.57+26% CAGR
2028$68.37 – $100.28+7% CAGR$351.15 – $515.02+37% CAGR$233.86 – $343.00+20% CAGR
2029$69.74 – $102.28+5% CAGR$458.15 – $671.95+35% CAGR$268.66 – $394.03+19% CAGR
2030$71.13 – $104.33+4% CAGR$597.74 – $876.69+34% CAGR$308.64 – $452.67+18% CAGR
2031$72.55 – $106.41+4% CAGR$779.88 – $1,143.82+33% CAGR$354.56 – $520.02+17% CAGR
5-yr CAGR-3.7% – 4.0%23.2% – 33.0%8.5% – 17.1%